Abbott to spin off $8.5B nutrition unit
Alpha Vantage · TipRanks · · AI-summarised by FinFlash
Abbott Laboratories shares fell 4% in pre-market trading after the company said it will separate its global Nutrition business into an independent, publicly traded company by the end of next year. The new entity, with $8.5 billion in annual sales, will focus on healthy nutrition, while Abbott concentrates on medical devices, diagnostics and established medicines.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.